Psychemedics Corporation (PMD) Stock Overview
Explore Psychemedics Corporation’s financial performance, market position, analyst ratings, and future outlook.
Psychemedics Corporation (PMD)
Key Financials
Key Financials
Market Cap
15.6M
P/E Ratio
-8.34
EPS (TTM)
$-0.51
ROE
-0.32%
PMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Psychemedics Corporation (PMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.34 and a market capitalization of 15.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.